MedPath
NMPA Approval

Montelukast Sodium Oral Granules

国药准字HJ20171062

February 6, 2024

H20171062

Drug Information

孟鲁司特钠颗粒

顺尔宁

颗粒剂

4mg(以孟鲁司特计)

化学药品

February 6, 2024

February 5, 2029

Company Information

Applicant Company

30 Hudson St Fl33,Jersey City, NJ 07302 United States of America

Manufacturing Company

5900 Martin Luther King Jr. Highway, Greenville, NC 27834 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

孟鲁司特钠颗粒 - NMPA 批准文号 | MedPath